AQEAX
Price
$16.25
Change
-$0.01 (-0.06%)
Updated
Jun 2 closing price
Net Assets
5.2B
RWMFX
Price
$68.79
Change
+$0.27 (+0.39%)
Updated
Jun 2 closing price
Net Assets
214.46B
Interact to see
Advertisement

AQEAX vs RWMFX

Header iconAQEAX vs RWMFX Comparison
Open Charts AQEAX vs RWMFXBanner chart's image
AQEAX vs RWMFX Comparison Chart in %
View a ticker or compare two or three
VS
AQEAX vs. RWMFX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AQEAX is a Hold and RWMFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWMFX has more cash in the bank: 214B vs. AQEAX (5.2B). RWMFX pays higher dividends than AQEAX: RWMFX (1.40) vs AQEAX (0.47). AQEAX was incepted earlier than RWMFX: AQEAX (23 years) vs RWMFX (24 years). AQEAX (0.94) is less costly to investors than RWMFX (0.31). AQEAX is a more actively managed with annual turnover of: 49.00 vs. RWMFX (29.00). RWMFX has a lower initial minimum investment than AQEAX: RWMFX (250) vs AQEAX (2000). AQEAX annual gain was more profitable for investors over the last year : 12.71 vs. RWMFX (8.10). RWMFX return over 5 years is better than : 26.71 vs. AQEAX (13.39).
AQEAXRWMFXAQEAX / RWMFX
Total Expense Ratio0.940.31303%
Annual Report Gross Expense Ratio0.940.31303%
Fund Existence23 years24 years-
Gain YTD7.8255.575140%
Front Load6%N/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets5.2B214B2%
Annual Yield % from dividends0.471.4034%
Returns for 1 year12.718.10157%
Returns for 3 years36.3533.11110%
Returns for 5 years13.3926.7150%
Returns for 10 years76.4085.4289%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLS472.4045.85
+10.75%
Celestica
EMBC3.470.18
+5.62%
Embecta Corp
MOGU2.180.08
+3.81%
MOGU
MRP27.830.10
+0.36%
Millrose Properties Inc
CGEM15.34-0.87
-5.37%
Cullinan Therapeutics